Loading....
Start Date
Start Time - End Time
WEBINAR DESCRIPTION
In this webinar, Dr. Sandrine Niyongere will discuss the latest research presented at EHA and ASCO on MDS and AML. This is an advanced presentation. There will be a Q & A session and questions can be submitted in advance to [email protected].
Thank you to our 2026 Sponsors.
Diamond Level
Silver Level
Bronze Level
Edit this section of copy to tell your supporters how their action will help ignite change. Use stories, quotes, data, and other inspiring content to capture their attention and get them to act.
WEBINAR FACULTY
Dr. Niyongere joined the School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center as an Assistant Professor in 2018. Her clinical focus is in acute leukemias, myelodysplastic syndromes, myeloproliferative neoplasms and bone marrow failure syndromes.
Dr. Niyongere’s primary research interests are in finding new therapeutic targets by understanding oncogenic signaling pathways involved in AML and MDS as well as studying the role of the tumor microenvironment in the development of chemoresistance in leukemia.
Thank you for registering for this webinar.
You will receive an email with a registration confirmation including the webinar link
and a call-in phone # for those participating via telephone.
If you do not receive the link, please check your Spam/Junk folders.
If you have not received a registration confirmation, please email [email protected]
or call (800) 747-2820 x2 no later than 30 minutes before the webinar is scheduled to begin.
If you are not able to join the webinar, an archived video will be available in 2 - 3 business days on the AAMDSIF website.